comparemela.com

Latest Breaking News On - Dianem sullivan - Page 5 : comparemela.com

Caleres (NYSE:CAL) Shares Up 4 4%

Caleres, Inc. (NYSE:CAL – Get Rating) shot up 4.4% on Friday . The stock traded as high as $22.69 and last traded at $22.66. 19,502 shares were traded during trading, a decline of 97% from the average session volume of 646,235 shares. The stock had previously closed at $21.70. Analysts Set New Price Targets Several […]

StockNews com Upgrades Caleres (NYSE:CAL) to Buy

StockNews.com upgraded shares of Caleres (NYSE:CAL – Get Rating) from a hold rating to a buy rating in a research note released on Monday. Separately, Piper Sandler raised shares of Caleres from a neutral rating to an overweight rating and increased their target price for the stock from $26.00 to $35.00 in a research note […]

Caleres, Inc (NYSE:CAL) Given Consensus Rating of Buy by Brokerages

Shares of Caleres, Inc. (NYSE:CAL – Get Rating) have been given an average rating of “Buy” by the six research firms that are currently covering the stock, Marketbeat reports. Three research analysts have rated the stock with a buy rating. The average twelve-month price target among brokerages that have issued a report on the stock […]

Caleres (NYSE:CAL) Trading Down 2 8%

Caleres, Inc. (NYSE:CAL – Get Rating) shares traded down 2.8% during mid-day trading on Wednesday . The company traded as low as $20.86 and last traded at $20.92. 74,882 shares were traded during mid-day trading, a decline of 89% from the average session volume of 688,143 shares. The stock had previously closed at $21.52. Wall […]

Caleres, Inc (NYSE:CAL) Given Average Rating of Hold by Analysts

Shares of Caleres, Inc. (NYSE:CAL – Get Rating) have been given an average recommendation of “Hold” by the six brokerages that are currently covering the stock, MarketBeat.com reports. Two analysts have rated the stock with a hold recommendation and one has assigned a buy recommendation to the company. The average 12-month price target among brokers […]

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.